statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	751
SG - Singapore	188
VN - Vietnam	96
UA - Ucraina	93
CN - Cina	85
IT - Italia	83
BR - Brasile	80
DE - Germania	65
SE - Svezia	47
IN - India	35
AT - Austria	34
FI - Finlandia	25
BD - Bangladesh	21
FR - Francia	19
CA - Canada	18
KR - Corea	17
HK - Hong Kong	16
RU - Federazione Russa	14
TR - Turchia	14
AR - Argentina	13
GB - Regno Unito	10
MX - Messico	10
SN - Senegal	10
ID - Indonesia	7
JP - Giappone	7
ZA - Sudafrica	7
EC - Ecuador	6
IQ - Iraq	6
PK - Pakistan	5
BE - Belgio	4
ES - Italia	4
MY - Malesia	4
PL - Polonia	4
TN - Tunisia	4
CO - Colombia	3
NL - Olanda	3
UZ - Uzbekistan	3
CL - Cile	2
CZ - Repubblica Ceca	2
DO - Repubblica Dominicana	2
EG - Egitto	2
GE - Georgia	2
JO - Giordania	2
KE - Kenya	2
LT - Lituania	2
MA - Marocco	2
NP - Nepal	2
QA - Qatar	2
SY - Repubblica araba siriana	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AZ - Azerbaigian	1
BO - Bolivia	1
CH - Svizzera	1
CR - Costa Rica	1
DZ - Algeria	1
GR - Grecia	1
KG - Kirghizistan	1
KW - Kuwait	1
LA - Repubblica Popolare Democratica del Laos	1
LK - Sri Lanka	1
LV - Lettonia	1
MN - Mongolia	1
PA - Panama	1
PE - Perù	1
PH - Filippine	1
PS - Palestinian Territory	1
PY - Paraguay	1
RO - Romania	1
SA - Arabia Saudita	1
Totale	1.857

Nome	#
After wine: typical white Calabrian grape pomaces as useful source of functional foods	214
Quercetin/oleic acid-based G-protein-coupled receptor 40 ligands as new insulin secretion modulators	211
Proceedings of the Merck & Elsevier Young Chemists Symposium (MEYCS 2018)	200
2,3-Dihydroquinazolin-4(1H)-one as a privileged scaffold in drug design	195
Synthesis and Experimental Validation of New PDI Inhibitors with Antiproliferative Activity,	182
Quercetin and its Natural Sources in Wound Healing Management	165
Discovery of 1,4-Naphthoquinones as a New Class of Antiproliferative Agents Targeting GPR55	165
Primo classificato della categoria Life Science con il Progetto RYGoldZip al PNI (premio Naizonale per l'Innovazione) 2017 vincitore del premio Clinic Center Life Sciences del valore di 25.000,00 euro.	149
Triazolopyrimidinium salts: discovery of a new class of agents for cancer therapy	146
Identification of novel 2-(1 H-indol-1-yl)-benzohydrazides CXCR4 ligands impairing breast cancer growth & motility	139
Design and synthesis of new Transient Receptor Potential Vanilloid Type-1 (TRPV1) channel modulators: identification, molecular modelling analysis and pharmacological characterization of the N-(4-hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide, a small molecule endowed with agonist TRPV1 activity and protective effects against oxidative stress	127
Totale	1.893

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	7	0	0	0	0	0	0	0	0	0	0	0	7
2021/2022	167	0	27	6	32	12	2	2	34	7	1	16	28
2022/2023	205	15	33	7	31	31	21	0	18	19	4	21	5
2023/2024	185	21	13	19	10	8	34	14	23	9	10	1	23
2024/2025	274	26	24	13	15	13	19	10	28	44	25	25	32
2025/2026	767	71	31	136	49	123	66	98	33	53	53	24	30
Totale													1.893